Tango Therapeutics, Inc. (TNGX): Price and Financial Metrics
TNGX Price/Volume Stats
| Current price | $5.15 | 52-week high | $13.01 |
| Prev. close | $5.43 | 52-week low | $5.07 |
| Day low | $5.07 | Volume | 2,706,300 |
| Day high | $5.47 | Avg. volume | 781,317 |
| 50-day MA | $8.17 | Dividend yield | N/A |
| 200-day MA | $8.94 | Market Cap | 551.79M |
TNGX Stock Price Chart Interactive Chart >
Tango Therapeutics, Inc. (TNGX) Company Bio
Tango Therapeutics, Inc., a biotechnology company, discovers and develops medicines for the treatment of cancer. Its lead program is TNG908, a protein arginine methyl transferase 5 inhibitor that is being developed as a treatment for cancers with MTAP deletions. The company also develops Ubiquitin-specific protease 1, an inhibitor that treats cancers with BRCA1 mutations. Tango Therapeutics, Inc. has strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is based in Cambridge, Massachusetts.
TNGX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...